Omeros Stock

Omeros Forward P/E

The Forward P/E Ratio of Omeros (OMER) as of Aug 19, 2026 is -247.41. In the previous year, Forward P/E Ratio was -5.29 — a change of 4,581.04% (lower).

Forward P/E

-247.41

YoY

4,581.04%

Last updated:

Forward P/E Ratio of Omeros is 2026 -247.41 . Forward P/E Ratio of Omeros was 2025 -5.29 . It decreases by 4,581.04% lower compared to the previous year.
Access this data via the Eulerpool API

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Omeros stock

Forward P/E Ratio of Omeros is -247.41 in 2026.

Forward P/E Ratio of Omeros changed from -5.29 to -247.41, representing a 4,581.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Omeros since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Omeros with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Omeros

All Key Metrics — Omeros